Cargando…
Case series: pachychoroid pigment epitheliopathy transformed to polypoidal choroidal vasculopathy after long-term follow-up
BACKGROUND: Pachychoroid pigment epitheliopathy (PPE), a retinal disorder that falls into the pachychoroid spectrum, is characterized by retinal pigment epithelium changes in pachychoroid eyes without existing or previous subretinal fluid or soft drusen. Previous reports have indicated that PPE may...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210595/ https://www.ncbi.nlm.nih.gov/pubmed/35729590 http://dx.doi.org/10.1186/s12886-022-02487-8 |
_version_ | 1784730190086144000 |
---|---|
author | Tang, Jiyang Han, Xinyao Tang, Ran Li, Mengyang Wang, Zongyi Zhao, Mingwei Qu, Jinfeng |
author_facet | Tang, Jiyang Han, Xinyao Tang, Ran Li, Mengyang Wang, Zongyi Zhao, Mingwei Qu, Jinfeng |
author_sort | Tang, Jiyang |
collection | PubMed |
description | BACKGROUND: Pachychoroid pigment epitheliopathy (PPE), a retinal disorder that falls into the pachychoroid spectrum, is characterized by retinal pigment epithelium changes in pachychoroid eyes without existing or previous subretinal fluid or soft drusen. Previous reports have indicated that PPE may share some pathophysiologic component with other pachychoroid spectrum diseases and could transform into central serous chorioretinopathy (CSC) during follow-up. CSC transformation to PNV and PCV has also been reported, but PPE transformation to PCV has not been reported. CASE PRESENTATION: Seven eyes of seven patients (four male three female, aged 62.7 ± 8.4 years) who presented with PPE at baseline transformed to PCV during follow-up. All study eyes had baseline contralateral eye diagnoses of PCV. All PPE eyes reported no symptoms at baseline and were followed up regularly for the treatment of their contralateral eyes. All PPE presented as pigment epithelium detachment (PED) at baseline. The mean central macular thickness (CMT) was 217.6 ± 14.6 µm, the mean subfoveal choroidal thickness (SFCT) was 354.9 ± 94.9 µm, and the mean sub-PPE choroidal thickness was 332.3 ± 84.6 µm. The mean PPE width and height were 1326.4 ± 791.4 µm and 58.7 ± 23.6 µm, respectively, at baseline. Disruption of the ellipsoid zone (EZ) was noted in 3 eyes, while choroidal vascular hyperpermeability (CVH) was noted in 5 eyes at baseline. The follow-up period was 75.0 ± 41.1 months, and the mean transformation time was 49.6 ± 24.8 months. All study eyes received no intervention before transformation. CONCLUSIONS: PPE could transform to PCV after a long follow-up period. Regular follow-ups for a long time should be recommended for patients with PPE. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12886-022-02487-8. |
format | Online Article Text |
id | pubmed-9210595 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-92105952022-06-22 Case series: pachychoroid pigment epitheliopathy transformed to polypoidal choroidal vasculopathy after long-term follow-up Tang, Jiyang Han, Xinyao Tang, Ran Li, Mengyang Wang, Zongyi Zhao, Mingwei Qu, Jinfeng BMC Ophthalmol Case Report BACKGROUND: Pachychoroid pigment epitheliopathy (PPE), a retinal disorder that falls into the pachychoroid spectrum, is characterized by retinal pigment epithelium changes in pachychoroid eyes without existing or previous subretinal fluid or soft drusen. Previous reports have indicated that PPE may share some pathophysiologic component with other pachychoroid spectrum diseases and could transform into central serous chorioretinopathy (CSC) during follow-up. CSC transformation to PNV and PCV has also been reported, but PPE transformation to PCV has not been reported. CASE PRESENTATION: Seven eyes of seven patients (four male three female, aged 62.7 ± 8.4 years) who presented with PPE at baseline transformed to PCV during follow-up. All study eyes had baseline contralateral eye diagnoses of PCV. All PPE eyes reported no symptoms at baseline and were followed up regularly for the treatment of their contralateral eyes. All PPE presented as pigment epithelium detachment (PED) at baseline. The mean central macular thickness (CMT) was 217.6 ± 14.6 µm, the mean subfoveal choroidal thickness (SFCT) was 354.9 ± 94.9 µm, and the mean sub-PPE choroidal thickness was 332.3 ± 84.6 µm. The mean PPE width and height were 1326.4 ± 791.4 µm and 58.7 ± 23.6 µm, respectively, at baseline. Disruption of the ellipsoid zone (EZ) was noted in 3 eyes, while choroidal vascular hyperpermeability (CVH) was noted in 5 eyes at baseline. The follow-up period was 75.0 ± 41.1 months, and the mean transformation time was 49.6 ± 24.8 months. All study eyes received no intervention before transformation. CONCLUSIONS: PPE could transform to PCV after a long follow-up period. Regular follow-ups for a long time should be recommended for patients with PPE. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12886-022-02487-8. BioMed Central 2022-06-21 /pmc/articles/PMC9210595/ /pubmed/35729590 http://dx.doi.org/10.1186/s12886-022-02487-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Tang, Jiyang Han, Xinyao Tang, Ran Li, Mengyang Wang, Zongyi Zhao, Mingwei Qu, Jinfeng Case series: pachychoroid pigment epitheliopathy transformed to polypoidal choroidal vasculopathy after long-term follow-up |
title | Case series: pachychoroid pigment epitheliopathy transformed to polypoidal choroidal vasculopathy after long-term follow-up |
title_full | Case series: pachychoroid pigment epitheliopathy transformed to polypoidal choroidal vasculopathy after long-term follow-up |
title_fullStr | Case series: pachychoroid pigment epitheliopathy transformed to polypoidal choroidal vasculopathy after long-term follow-up |
title_full_unstemmed | Case series: pachychoroid pigment epitheliopathy transformed to polypoidal choroidal vasculopathy after long-term follow-up |
title_short | Case series: pachychoroid pigment epitheliopathy transformed to polypoidal choroidal vasculopathy after long-term follow-up |
title_sort | case series: pachychoroid pigment epitheliopathy transformed to polypoidal choroidal vasculopathy after long-term follow-up |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210595/ https://www.ncbi.nlm.nih.gov/pubmed/35729590 http://dx.doi.org/10.1186/s12886-022-02487-8 |
work_keys_str_mv | AT tangjiyang caseseriespachychoroidpigmentepitheliopathytransformedtopolypoidalchoroidalvasculopathyafterlongtermfollowup AT hanxinyao caseseriespachychoroidpigmentepitheliopathytransformedtopolypoidalchoroidalvasculopathyafterlongtermfollowup AT tangran caseseriespachychoroidpigmentepitheliopathytransformedtopolypoidalchoroidalvasculopathyafterlongtermfollowup AT limengyang caseseriespachychoroidpigmentepitheliopathytransformedtopolypoidalchoroidalvasculopathyafterlongtermfollowup AT wangzongyi caseseriespachychoroidpigmentepitheliopathytransformedtopolypoidalchoroidalvasculopathyafterlongtermfollowup AT zhaomingwei caseseriespachychoroidpigmentepitheliopathytransformedtopolypoidalchoroidalvasculopathyafterlongtermfollowup AT qujinfeng caseseriespachychoroidpigmentepitheliopathytransformedtopolypoidalchoroidalvasculopathyafterlongtermfollowup |